Cargando…

Evidence for short duration of antibiotic treatment for non-severe community acquired pneumonia (CAP) in children — are we there yet? A systematic review of randomised controlled trials

Context: The ideal duration of antibiotic treatment for childhood community acquired pneumonia (CAP) has not yet been established. Objective: A literature search was conducted to evaluate the efficacy of shorter than 7 days duration of oral antibiotic treatment for childhood non-severe CAP. Data sou...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ben-Shimol, Shalom, Levy-Litan, Varda, Falup-Pecurariu, Oana, Greenberg, David
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5922321/ https://www.ncbi.nlm.nih.gov/pubmed/31641568 http://dx.doi.org/10.15172/pneu.2014.4/432

Ejemplares similares

The Dashboard Vitals of Parkinson’s: Not to Be Missed Yet an Unmet Need
por: Chaudhuri, Kallol Ray, et al.
Publicado: (2022)

Procalcitonin guidance significantly reduces antibiotic duration in community-acquired pneumonia: the 'ProCAP' study
por: Christ-Crain, M, et al.
Publicado: (2005)

Comparison between diagnosis and treatment of community-acquired pneumonia in children in various medical centres across Europe with the United States, United Kingdom and the World Health Organization guidelines
por: Usonis, Vytautas, et al.
Publicado: (2016)

1940. Real-Life Impact of Pneumococcal Conjugate Vaccines (PCVs) on Hospitalization of Young Children with RSV-Associated Community-acquired Alveolar Pneumonia (CAAP)
por: Dagan, Ron, et al.
Publicado: (2023)

Characterization of children younger than 5 Years of age with severe community-acquired alveolar pneumonia (CAAP) requiring Pediatric Intensive Care Unit (PICU) admission
por: Feinstein, Yael, et al.
Publicado: (2020)

2203. Involvement of Respiratory Viruses in Community-Acquired Alveolar Pneumonia (CAAP) in Children < 5 Years in Southern Israel, Before and During the COVID-19 Pandemic
por: Danino, Dana, et al.
Publicado: (2022)

2618. Four Respiratory Viruses are Involved in the Majority of Community-Acquired Alveolar Pneumonia (CAAP) Episodes in Children < 5 Years
por: Dagan, Ron, et al.
Publicado: (2023)

Shiga toxin producing Escherichia coli-associated diarrhea and hemolytic uremic syndrome in young children in Romania
por: Falup-Pecurariu, Oana, et al.
Publicado: (2019)

Impact of pneumococcal conjugate vaccines introduction on antibiotic resistance of Streptococcus pneumoniae meningitis in children aged 5 years or younger, Israel, 2004 to 2016
por: Ben-Shimol, Shalom, et al.
Publicado: (2018)

Are We Floating Yet? Duration of Fixed Exchange Rate Regimes
por: Bizuneh, Menna
Publicado: (2021)

1646. Optimizing Antibiotic Durations of Therapy in Pediatric Community-acquired Pneumonia
por: Cook, Gregory, et al.
Publicado: (2023)

Comparison of early onset sepsis and community-acquired late onset sepsis in infants less than 3 months of age
por: Bulkowstein, Shlomi, et al.
Publicado: (2016)

Short-course antibiotic therapy of 5 days in community-acquired pneumonia (CAP5): study protocol for a randomised controlled trial
por: Israelsen, Simone Bastrup, et al.
Publicado: (2023)

Personalized Assessment of Insomnia and Sleep Quality in Patients with Parkinson’s Disease
por: Diaconu, Ştefania, et al.
Publicado: (2022)

1433. Association Between Impact of Pneumococcal Conjugate Vaccines (PCVs) on Acute Respiratory Infections Rates and Impact on Antibiotic Consumption Rates in Young Children
por: Dagan, Ron, et al.
Publicado: (2018)

Urgent start peritoneal dialysis: are we there yet?
por: Greenberg, Keiko I., et al.
Publicado: (2020)

Antibiotic Prescription Rates in Children <24 Months Old Following PCV7/PCV13 Sequential Implementation
por: Dagan, Ron, et al.
Publicado: (2017)

1431. Dynamics of Antibiotic Prescription Rate Following Pneumococcal Conjugate Vaccine (PCV) Implementation in Children <2 Years Old: Comparison Between High and Low Prescribing Clinics in Two Different Ethnic Groups
por: Danino, Dana, et al.
Publicado: (2018)

Prescription of antibiotics in community-acquired pneumonia in children: are we following the recommendations?
por: da Fonseca Lima, Eduardo Jorge, et al.
Publicado: (2016)

The Science of Selecting Antimicrobials for Community-Acquired Pneumonia (CAP)
por: File, Thomas M.
Publicado: (2009)

Are we there yet?
por: Wise, Jo Ann
Publicado: (2015)

Are we there yet?
por: Swann, Nicole
Publicado: (2019)

Are we there yet?
por: McCann, Shaun R.
Publicado: (2022)

261. Alternative Antibiotic Prescribing for Community Acquired Pneumonia (CAP) in Pediatric Patients in Relation to Allergy Status
por: Desai, Ankita, et al.
Publicado: (2018)

Impact of reducing the duration of antibiotic treatment on the long-term prognosis of community acquired pneumonia
por: Uranga MD, Ane, et al.
Publicado: (2020)

Optimal duration of antibiotic treatment for community-acquired pneumonia in adults: a systematic review and duration-effect meta-analysis
por: Furukawa, Yuki, et al.
Publicado: (2023)

Efficacy, safety and impact on antimicrobial resistance of duration and dose of amoxicillin treatment for young children with Community-Acquired Pneumonia: a protocol for a randomIsed controlled Trial (CAP-IT)
por: Lyttle, Mark D, et al.
Publicado: (2019)

SARS-CoV-2 and Parkinson’s Disease: A Review of Where We Are Now
por: Boura, Iro, et al.
Publicado: (2023)

Correction to: Impact of reducing the duration of antibiotic treatment on the long-term prognosis of community acquired pneumonia
por: Uranga, Ane, et al.
Publicado: (2021)

O01 Auditing the duration of antibiotic therapy for children treated as inpatients for community acquired pneumonia
por: Alexander, Emma, et al.
Publicado: (2023)

Disproportionate reduction in respiratory vs. non-respiratory outpatient clinic visits and antibiotic use in children during the COVID-19 pandemic
por: Givon-Lavi, Noga, et al.
Publicado: (2022)

An evaluation of prescribing practices for community-acquired pneumonia (CAP) in Mongolia
por: Dorj, Gereltuya, et al.
Publicado: (2013)

Editorial: Movement Disorders and Sleep – Underlying Mechanisms, Clinical Aspects and Treatment
por: Falup-Pecurariu, Cristian, et al.
Publicado: (2019)

Are we nearly there yet?
por: Battersby, Stephen
Publicado: (2005)

Why Are We Not There Yet?
por: Wenger, Nanette K.
Publicado: (2021)

Comparison of viral infection in healthcare-associated pneumonia (HCAP) and community-acquired pneumonia (CAP)
por: Kim, Eun Sun, et al.
Publicado: (2018)

Long-term effects of intrajejunal levodopa infusion on sleep in people with advanced Parkinson's disease
por: Diaconu, Ştefania, et al.
Publicado: (2023)

Außerhalb des Krankenhauses erworbene Pneumonie (community acquired pneumonia CAP)
por: Wenisch, Christoph, et al.
Publicado: (2006)

Legionella community-acquired pneumonia (CAP) presenting with spontaneous bilateral pneumothoraces
por: Cunha, Burke A., et al.
Publicado: (2008)

Antibiotic preferences and treatment durations in community-acquired infections
por: Ertunc, Baris, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_a6guhd1bepnf63djei8mlis58g